A novel bivalent morphine/heroin vaccine that prevents relapse to heroin addiction in rodents

Vaccine

Volumn 24, Issue 16, 2006, Pages 3232-3240

  Anton, Benito ^a   Leff, Philippe ^a  

^a INSTITUTO NACIONAL DE PSIQUIATRÍA RAMÓN DE LA FUENTE MUÑIZ   (Mexico)

Author keywords

Active immunization; Addiction; Immunoprotection; Morphine heroin; Opiates; Prevention; Vaccine

Indexed keywords

BUPRENORPHINE; CARRIER PROTEIN; COCAINE; DIAMORPHINE; HAPTEN; METHADONE; MORPHINE; MORPHINE TETANUS TOXOID ANTIBODY; NALTREXONE; NICOTINE; OPIATE; UNCLASSIFIED DRUG; VACCINE;

ACTIVE IMMUNIZATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ARTICLE; CONTROLLED STUDY; CROSS REACTION; DOSE RESPONSE; DRUG EFFECT; DRUG SELF ADMINISTRATION; DRUG STRUCTURE; DRUG SYNTHESIS; HEROIN DEPENDENCE; HUMORAL IMMUNITY; IMMUNOGENICITY; NONHUMAN; OPIATE ADDICTION; PRIORITY JOURNAL; RAT; RELAPSE; TREATMENT FAILURE;

ANIMALS; ANTIBODIES; ANTIBODY SPECIFICITY; CROSS REACTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HAPTENS; HEROIN; HEROIN DEPENDENCE; MALE; MODELS, ANIMAL; MODELS, CHEMICAL; MORPHINE; MORPHINE DEPENDENCE; RATS; RECURRENCE; TETANUS TOXOID; VACCINES, CONJUGATE;

EID: 33645064261     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.01.047     Document Type: Article

References (37)

1. P.N. Deslandes, D.M. Pache, and D.E. Sewell Drug dependence: neuropharmacology and management J Pharm Pharmacol 54 7 2002 885 895
2. E.J. Nestler From neurobiology to treatment: progress against addiction Nat Neurosci 5 Suppl. 2002 1076 1079
3. A.K. Sevarino, A. Olliveto, and R.T. Kosten Neurobiological adaptations to psychostimulants and opiates as a basis of treatment development Ann N Y Acad Sci 90 2000 51 87
4. N.W. Withers, L. Pulvirenti, G.F. Koob, and J.C. Gillin Cocaine abuse and dependence J Clin Psychopharmacol 15 1 1995 63 78
5. G. Schulteis, and G.F. Koob Reinforcement processes in opiate addiction: a homeostatic model Neurochem Res 21 11 1996 1437 1454
6. M.J. Kreek Methadone-related opiod agonist pharmacotherapy for heroin addiction: history, recent molecular and neurochemical research and future mainstream medicine Ann N Y Acad Sci 909 2000 186 216
7. C.P. O'Brien A range of research-based pharmacotherapies for addiction Science 278 5335 1997 66 70
8. G.F. Koob, P.P. Sanna, and F.E. Bloom Neuroscience of addiction Neuron 21 3 1998 467 476
9. R.T. Kosten, and D. Biegel Therapeutic vaccines for substance dependence Expert Rev Vaccines 1 3 2003 89 97
10. K.M. Kantak Vaccines against drug of abuse. A viable treatment option? Drugs 63 4 2003 341 351
11. B.A. Martell, E. Mitchell, J. Poling, K. Gonsai, and T.R. Kosten Vaccine pharmacotherapy for the treatment of cocaine dependence Biol Psychiatry 58 2005 158 164
12. K.F. Bonese, B.H. Wainer, F.W. Fitch, R.M. Rothberg, and C.R. Schuster Changes in heroin self-administration by a rhesus monkey after morphine immunization Nature 252 5485 1974 708 710
13. W. van den Brink, and J.M. van Ree Pharmacological treatments for heroin and cocaine addiction Eur Neuropsychopharmacol 13 6 2003 476 487
14. E.J. Simon, W.P. Dole, and J.M. Hiller Coupling of a new, active morphine derivative to sepharose for affinity chromatography Proc Natl Acad Sci USA 69 7 1972 1835 1837
15. B.H. Wainer, F.W. Fitch, R.M. Rothberg, and J. Fried Morphine-3-succinyl- bovine serum albumin: an immunogenic hapten-protein conjugate Science 176 39 1973 1143 1145
16. 14C-morphine binding J Immunol 110 3 1973 667 673
17. T.J. Martin, S.I. Dworkin, and J.E. Smith Alkylation of mu opioid receptor by beta-funaltrexamine in vivo: comparison of the effects on in situ binding and heroin self-administration in rats J Pharmacol Exp Ther 272 3 1995 1135 1140
18. E. Harlow, and D. Lane Immunizations 1st ed. E. Harlow D. Lane Antibodies, a laboratory manual vol. 1 1988 Cold Spring Harbor Laboratory New York, USA 55 136 [Chapter 5]
19. N. Gamaleya, F. Tagliaro, A. Parshin, A. Vrublevskii, G. Bugari, and R. Dorizzi Immune response to opiates: new findings in heroin addicts investigated by means of an original enzyme immunoassay and morphine determination in hair Life Sci 53 2 1993 99 105
20. M.W. Steward Overview: introduction to methods used to study the affinity and kinetics of antibody-antigen reactions 4th ed. D.M. Weir Handbook of experimental immunology vol. 1 1986 Blackwell Scientific Inc. Oxford, England [Chapter 25]
21. M.R. Carrera, G. Schulteis, and G.F. Koob Heroin self-administration in dependent wistar rats: increased sensitivity to naloxone Psychopharmacol (Berl) 144 2 1999 111 120
22. P.H. Dennehy Active immunization in the United States: developments over the past decade Clin Microbiol Rev 14 4 2001 872 908
23. M.H.V. Van Regenmortel Antigenicity and inmunogenicity of synthetic peptides Biologicals 29 3-4 2001 209 213
24. M.H.V. Van Regenmortel From absolute to exquisite specificity. Reflections on the fuzzy nature of species, specificity and antigenic sites J Immunol Methods 216 1-2 1998 37 48
25. A.J. Berzofsky, and J.I. Berkahuer Regulation of Immune response: immunogenicity and antigen structure E.W. Paul Fundamental immunology 5th ed. 2003 Lippincott, Wlliams & Wilkins Inc. Philadelphia, PA 631 684 [Chapter 21]
26. Anton B, Leff P. Intravenous self-administration of morphine and heroin is prevented after active immunization with a morphine vaccine in the rodent. In: 63rd annual meeting of the college on problems of drug dependence (CPDD/NIDA); 2001.
27. Anton B, Leff P. Addictive morphine and heroin self-administration behavior is prevented after active immunization with a morphine vaccine in the rodent. Soc. Neurosci. Abstr., vol. 27, Program No. 685.7; 2001.
28. H. Van Vunakis, E. Wasserman, and L. Levine Specificities of antibodies to morphine J Pharmacol Exper Ther 180 2 1972 514 521
29. S.J. Gross, D. Grant, S.R. Wong, and R. Schuster Critical antigenic determinants for production of antibody to distinguish morphine from heroin, codeine and dextromethorphan Immunochemistry 11 8 1974 453 456
30. T. Usagawa, Y. Itoh, E. Hifumi, A. Takeyasu, Y. Nakahara, and T. Uda Characterization of morphine-specific monoclonal antibodies showing minimal cross-reactivity with codeine J Immunol Methods 157 1-2 1993 143 148
31. L.M. Kamendulis, M.R. Brzezinski, E.V. Pindel, W.F. Bosron, and R.A. Dean Metabolism of cocaine and heroin is catalyzed by the same human liver carboxylesterases J Pharmacol Exp Ther 279 2 1996 713 717
32. G.P. Brown, K. Yang, O. Ouerfelli, K.M. Standifer, D. Byrd, and G.W. Pasternak 3H-morphine-6-beta-glucuronide binding in brain membranes and an MOR-1-transfected cell line J Pharmacol Exp Ther 282 3 1997 1291 1297
33. A.J. Halliday, S.E. Bartlett, P. Colitz, and M.T. Smith Brain region-specific studies of the excitatory behavioral effects of morphine-3-glucuronide Life Sci 65 2 1999 225 236
34. D.E. Selley, C.C. Cao, T. Sexton, J.A. Schwegel, T.J. Martin, and S.R. Childers mu-Opioid receptor-mediated G-protein activation by heroin metabolites: evidence for greater efficacy of 6-monoacetylmorphine compared with morphine Biochem Pharmacol 62 4 2001 447 455
35. K.J. Mantione, Y. Goumon, T. Esch, and G.B. Stefano Morphine 6-beta glucuronide: fortuitous morphine metabolite or preferred peripheral regulatory opiate? Med Sci Monit 11 5 2005 MS43 MS46
36. B.A. Martell, E. Mitchell, J. Poling, K. Gonsai, and T.R. Kosten Vaccine pharmacotherapy for the treatment of cocaine dependence Biol Psychiatry 58 2005 158 164
37. P.G. O'Connor, and D.A. Fiellin Pharmacologic treatment of heroin-dependent patients Ann Intern Med 133 2000 40 54